99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.
PURPOSE: Radiolabelled interleukin-2 is a radiopharmaceutical used for the study of chronic inflammatory processes. (123)I-labelled interleukin-2 has successfully been used in a large number of patients affected by several immune-mediated diseases. (123)I, however, is expensive and not readily avai...
Main Authors: | Chianelli, M, Mather, S, Grossman, A, Sobnak, R, Fritzberg, A, Britton, K, Signore, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Comparison of relative renal function measured with either 99mTc-DTPA or 99mTc-EC dynamic scintigraphies with that measured with 99mTc-DMSA static scintigraphy
by: F. C. Domingues, et al.
Published: (2006-08-01) -
Thyroid uptake and scintigraphy using 99mTc pertechnetate: standardization in normal individuals
by: Celso Darío Ramos, et al. -
Comparison of 99mTc-DMSA, 99mTc-DTPA and 99mTc-MAG3 Renal Scintigraphy in the Calculation of Relative Renal Function
by: Fadime Demir, et al.
Published: (2020-06-01) -
Synchronous parathyroid adenoma and papillary thyroid cancer detected on 99mTc-sestamibi scintigraphy
by: Sameer Kamalakar Taywade, et al.
Published: (2016-01-01) -
What need is there for standardization of thyroid uptake or scintigraphy using 99mTc pertechnetate in thyroid disease diagnosis?
by: Egberto Gaspar de Moura